154 related articles for article (PubMed ID: 36458558)
1. Successful Haploidentical Hematopoietic Stem Cell Transplantation with Azacitidine and Venetoclax Maintenance Therapy for Acute Myeloid Leukemia with
Yuan J; Pei R; Lu Y
Turk J Haematol; 2023 Feb; 40(1):75-76. PubMed ID: 36458558
[No Abstract] [Full Text] [Related]
2. A novel NUP98/RARG gene fusion in acute myeloid leukemia resembling acute promyelocytic leukemia.
Such E; Cervera J; Valencia A; Barragán E; Ibañez M; Luna I; Fuster O; Perez-Sirvent ML; Senent L; Sempere A; Martinez J; Martín-Aragonés G; Sanz MA
Blood; 2011 Jan; 117(1):242-5. PubMed ID: 20935257
[TBL] [Abstract][Full Text] [Related]
3. Allogeneic stem cell transplantation can prolong the survival of patients with NUP98-rearranged acute myeloid leukemia.
Shen Y; Zhang T; Zhang L; Zhen S; Chen Z; Zhang R; Yang D; Wei J; He Y; Jiang E; Feng S
Bone Marrow Transplant; 2023 Oct; 58(10):1149-1151. PubMed ID: 37420010
[No Abstract] [Full Text] [Related]
4. Allogeneic hematopoietic stem cell transplantation for adult acute myeloid leukemia patients with nucleoporin 98 (NUP98) gene rearrangements: a real-world study in China.
Cao Y; Zhang C; Zhao X; Huang J; Zhang Z; Jiang C; Mo X; Hu X
Bone Marrow Transplant; 2023 Dec; 58(12):1413-1415. PubMed ID: 37730801
[No Abstract] [Full Text] [Related]
5. A Novel NUP98/RARG Gene Fusion in Pediatric Acute Myeloid Leukemia Resembling Acute Promyelocytic Leukemia.
Zhang J; Shen H; Song H; Shen D; Liao C; Fang M; Wang Y; Tang Y; Zhu H
J Pediatr Hematol Oncol; 2022 Apr; 44(3):e665-e671. PubMed ID: 35319505
[TBL] [Abstract][Full Text] [Related]
6. Identification of a recurrent fusion NUP98-RARG in acute myeloid leukaemia resembling acute promyelocytic leukaemia.
Wang M; Lin H; Chu X; Wang Z; Yang X; Cen J; Shen H; Pan J; Wang Y; Shen H; Chen S; Zhang X; Wen L; Yao L
Br J Haematol; 2022 Jun; 197(6):e73-e78. PubMed ID: 35421256
[No Abstract] [Full Text] [Related]
7. [Acute myeloid leukemia harboring NUP98::DDX10].
Kurita N; Kato T; Nanmoku T; Maruyama Y; Suehara Y; Hattori K; Sakamoto T; Yokoyama Y; Yoshida C; Tsuboi Y; Obara N; Nishikii H; Sakata-Yanagimoto M; Chiba S
Rinsho Ketsueki; 2022; 63(10):1397-1401. PubMed ID: 36351646
[TBL] [Abstract][Full Text] [Related]
8. Venetoclax plus azacitidine and donor lymphocyte infusion in treating acute myeloid leukemia patients who relapse after allogeneic hematopoietic stem cell transplantation.
Zhao P; Ni M; Ma D; Fang Q; Zhang Y; Li Y; Huang Y; Chen Y; Chai X; Zhan Y; Li Y; Kang Q; Zhao M; Liu M; Zhang F; Huang S; Wen S; Deng B; Wang J
Ann Hematol; 2022 Jan; 101(1):119-130. PubMed ID: 34568973
[TBL] [Abstract][Full Text] [Related]
9. Alkaloid-based regimen is beneficial for acute myeloid leukemia resembling acute promyelocytic leukemia with NUP98/RARG fusion and RUNX1 mutation: A case report.
Wei W; Liu Q; Song F; Cao H; Liu M; Jiang Y; Li Y; Gao S
Medicine (Baltimore); 2020 Oct; 99(40):e22488. PubMed ID: 33019444
[TBL] [Abstract][Full Text] [Related]
10. [Clinical observation on 16 cases of DEK-NUP214 fusion gene positive acute myeloid leukemia treated with allogeneic hematopoietic stem cell transplantation].
Xia J; Zhao Y; Wu XJ; Qiu HY; Tang XW; Wang Y; Jin ZM; Miao M; Ma X; Wu DP; Chen SN; Chen F
Zhonghua Xue Ye Xue Za Zhi; 2023 Dec; 44(12):1041-1044. PubMed ID: 38503531
[No Abstract] [Full Text] [Related]
11. In vitro all-trans retinoic acid sensitivity of acute myeloid leukemia blasts with NUP98/RARG fusion gene.
Such E; Cordón L; Sempere A; Villamón E; Ibañez M; Luna I; Gómez-Seguí I; López-Pavía M; Alonso C; Lo-Coco F; Cervera J; Sanz MA
Ann Hematol; 2014 Nov; 93(11):1931-3. PubMed ID: 24728721
[No Abstract] [Full Text] [Related]
12. Efficacy of venetoclax in combination with azacitidine followed by haploidentical transplantation in refractory acute myeloid leukaemia and mixed phenotype acute leukaemia.
Wu X; Zhang J; Chen Q; Zhou L; Li M; Qiu H; Sun A; Wu D
Br J Haematol; 2020 Jun; 189(5):e200-e204. PubMed ID: 32242923
[No Abstract] [Full Text] [Related]
13. Long-term molecular remission in a patient with acute myeloid leukemia harboring a new NUP98-LEDGF rearrangement.
Gallego Hernanz MP; Torregrosa Diaz JM; Sorel N; Bobin A; Dindinaud E; Bouyer S; Desmier D; Brizard F; Leleu X; Maillard N; Chomel JC
Cancer Med; 2019 Apr; 8(4):1765-1770. PubMed ID: 30848074
[TBL] [Abstract][Full Text] [Related]
14. Allogeneic hematopoietic cell transplantation for acute myeloid leukemia in first complete remission after 5-azacitidine and venetoclax: a multicenter retrospective study.
Pasvolsky O; Shimony S; Ram R; Shimoni A; Shargian L; Avni B; Wolach O; Shochat T; Yerushalmi R; Amit O; Raanani P; Yeshurun M
Ann Hematol; 2022 Feb; 101(2):379-387. PubMed ID: 34628534
[TBL] [Abstract][Full Text] [Related]
15. Exciting times ahead for older patients with acute myeloid leukemia: azacitidine and venetoclax followed by allogeneic hematopoietic cell transplantation.
Bazarbachi A
Bone Marrow Transplant; 2022 Feb; 57(2):147-148. PubMed ID: 34645927
[No Abstract] [Full Text] [Related]
16. Venetoclax and Azacitidine Treatment in Relapsed Acute Myeloid Leukemia after Hematopoietic Stem Cell Transplantation: A Cohort Study in the Real-World Setting of a Tertiary Center.
Göker H; Çınar OE; Demiroğlu H; Malkan ÜY; Aladağ Karakulak E; Büyükaşık Y
Turk J Haematol; 2023 Aug; 40(3):213-215. PubMed ID: 37314288
[No Abstract] [Full Text] [Related]
17. One plus one does not always equal two, especially with regard to hypomethylating agents: the question of synergy of azacitidine and lenalidomide for treatment of relapsed acute myeloid leukemia and myelodysplastic syndromes post allogeneic hematopoietic stem cell transplant.
Bewersdorf JP; Stahl M; Zeidan AM
Expert Rev Hematol; 2019 Aug; 12(8):575-578. PubMed ID: 31225770
[TBL] [Abstract][Full Text] [Related]
18. Acute myeloid leukemia patients with NUP98::NSD1 showing initially poor treatment response can benefit from FLT3 inhibitors and venetoclax as well as HSCT.
Sun H; Yan H; Yan Z; Zhu Y; Yang G; Zhang S
Ann Hematol; 2023 Feb; 102(2):473-475. PubMed ID: 36434435
[No Abstract] [Full Text] [Related]
19. NUP98-PHF23 fusion is recurrent in acute myeloid leukemia and shares gene expression signature of leukemic stem cells.
Ho H; Skaist AM; Pallavajjala A; Yonescu R; Batista D; Wheelan SJ; Ning Y
Leuk Res; 2016 Jun; 45():1-7. PubMed ID: 27060678
[TBL] [Abstract][Full Text] [Related]
20. Successful treatment of acute myeloid leukemia co-expressing NUP98/NSD1 and FLT3/ITD with preemptive donor lymphocyte infusions.
Mitani Y; Hiwatari M; Seki M; Hangai M; Takita J
Int J Hematol; 2019 Oct; 110(4):512-516. PubMed ID: 31134509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
